Combination therapies comprising IKZF2 degrader compounds

TW202639123APending Publication Date: 2026-10-01PLEXIUM INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114143554
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-08
Filing Date
2025-11-07
Publication Date
2026-10-01

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

Provided are combination use of compounds that mediate IKZF2 degradation with a second therapeutic agent or second therapy in the treatment of diseases or disorders involving IKZF2.
Need to check novelty before this filing date? Find Prior Art